CEFTAZIDIME

作品数：21被引量：36H指数：3
导出分析报告
相关领域：医药卫生更多>>
相关作者：王其南王浴生李显志凌保东吕余庆更多>>
相关机构：重庆医科大学华西医科大学军事医学科学院大连医科大学更多>>
相关期刊：《Engineering》《Asian Pacific Journal of Tropical Medicine》《中国新药杂志》《中国抗生素杂志》更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Transmission of ceftazidime-avibactam-resistant Escherichia coli among pets,veterinarians and animal hospital environment
《Biosafety and Health》2024年第3期191-198,共8页Hegen Dai Dongyan Shao Yu Song Qi An Zhenbiao Zhang Haixia Zhang Siyu Chen Congming Wu Jianzhong Shen Yanli Lyu Yang Wang Shizhen Ma Zhaofei Xia 
the National Natural Science Foundation of China(32141002,81991535 and 32202863);China Postdoctoral Science Foundation(2021 M703528).
Ceftazidime-avibactam (CZA) is a recently approved combination synthetic β-lactamase inhibitor used in human clinical medicine. Cases of CZA resistance in humans have already been reported, but limited research has i...
关键词：Ceftazidime-avibactam(CZA) Escherichia coli(E.coli) PETS Animal hospital environment VETERINARIANS 
Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction
《Acta Pharmacologica Sinica》2023年第9期1932-1934,共3页Yun-zhe Zheng Zhao-yuan Liu Yue Li Xiao-ying Lv Yi Wu Meng-wen Huang Xing-chao Pan Jian-feng Chen Chang-dong Lin 
supported by grants from National Key Research and Development Program of China (2020YFA0509000);National Natural Science Foundation of China (31830112,32030024,31525016 to JFC,32170769,31970702 to CDL);Shanghai Rising-Star Program (21QA1409700);Program of Shanghai Academic Research Leader (19XD1404200);Personalized Medicines-Molecular Signature-based Drug Discovery and Development,the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010101);the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2020266);the Young Elite Scientist Sponsorship Program by CAST (2019QNRC001);National Ten Thousand Talents Program,and the Fundamental Research Funds for the Central Universities (22120220378,22120220499).
Dear Editor,Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has coexisted with human beings over 3 years.It has undergone considerable evolution and several variants of concern(VOCs),including Alpha,Beta,Ga...
关键词：ACE2 acute respiratory 
Comparison of the Clinical Efficacy of Cefoperazone Sulbactam and Ceftazidime in the Treatment of Complicated Urinary Tract Infections
《外文科技期刊数据库(文摘版)医药卫生》2022年第10期088-092,共5页LUOHaiping 
Objective: to compare and analyze the clinical efficacy of cefoperazone sulbactam and ceftazidime in the treatment of complicated urinary tract infections and to provide a theoretical basis for the clinical drug treat...
关键词：cefoperazone sulbactam CEFTAZIDIME complicated urinary tract infection 
Epidemiology and Mechanisms of Ceftazidime-Avibactam Resistance in Gram-Negative Bacteria被引量：2
《Engineering》2022年第4期138-145,共8页Tingting Xu Yuqi Guo Yang Ji Baohong Wang Kai Zhou 
supported by the National Key Research and Development Program of China (2017YFC1200200);Major Infectious Diseases such as AIDS and Viral Hepatitis Prevention and Control Technology Major Projects (2018ZX10712-001);National Natural Science Foundation of China (81702045 and 81902030);Shenzhen Basic Research projects (JCYJ20190807144409307)
Carbapenem resistance presents a major challenge for the global public health network, as clinical infections caused by carbapenem-resistant organisms(CRO) are frequently associated with significant morbidity and mort...
关键词：Ceftazidime-avibactam Resistance mechanism CARBAPENEM-RESISTANT b-lactam/b-lactamase inhibitor 
Clinical Observation of Andrographolide Injection Combined with Ceftazidime in the Treatment of Children with Bronchial Pneumonia
《外文科技期刊数据库(文摘版)医药卫生》2022年第2期165-168,共4页YIHong 
Objective: to analyze the clinical effect of the injection combined with ceftazidime in the treatment of children with bronchial pneumonia. Methods: a total of 60 patients diagnosed with bronchial pneumonia in our hos...
关键词：bronchi pneumonia INJECTION CEFTAZIDIME clinical observation clinical efficacy 
Correction To:Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction被引量：1
《Signal Transduction and Targeted Therapy》2021年第7期2251-2251,共1页ChangDong Lin Yue Li YueBin Zhang ZhaoYuan Liu Xia Mu Chenjian Gu Jing Liu Yutang Li GuoHui Li JianFeng Chen 
After online publication of the article1 we noticed an error in citations for affiliation in the supplementary materials published in this article.The citations for affiliation in the article were reordered during the...
关键词：material. POTENTIAL reflected 
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction被引量：2
《Signal Transduction and Targeted Therapy》2021年第6期1671-1674,共4页ChangDong Lin Yue Li YueBin Zhang ZhaoYuan Liu Xia Mu Chenjian Gu Jing Liu Yutang Lr GuoHui Li JianFeng Chen 
grants from National Key Research and Development Program of China(2020YFA0509102);National Natural Science Foundation of China(32030024,31830112,31525016 to J.F.C.,31970702,31701219 to C.D.L.);Program of Shanghai Academic Research Leader(19XD1404200);Personalized Medicines-Molecular Signature-based Drug Discovery and Development,the Strategic Priority Research Program of the Chinese Academy of Sciences(XDA12010101);the Youth Innovation Promotion Association of the Chinese Academy of Sciences(2020266);the Young Elite Scientist Sponsorship Program by CAST(2019QNRC001);National Ten Thousand Talents Program.
Dear Editor,Coronavirus disease 2019(COVID-19)has spread globally as a severe pandemic,which is caused by a novel coronavirus named Severe Acute Respiratory Syndrome coronavirus 2(SARS-CoV-2).1 COVID-19 is a serious t...
关键词：ACE2 Acute LIKELY 
Detection and Characterization of β-Lactamase Encoding Genes in Carbapenem Non-Susceptible Gram-Negative Bacteria and Susceptibility of Isolates to Ceftazidime-Avibactam at a New York City Community Hospital
《Open Journal of Medical Microbiology》2016年第4期150-157,共8页Carl Urban Rita Colon-Urban Vincent J. LaBombardi Noriel Mariano Nishant Prasad Geeti Dhillon Marina Guralnik Sorana Segal-Maurer 
A surveillance study was undertaken to identify prominent β-lactamase encoding genes in 131 carbapenem non-susceptible gram-negative clinical isolates at a New York City community hospital. KPC carbapenemases were de...
关键词：Carbapenem Non-Susceptible Check-MDR CT103 XL Microarray β-Lactamase Detection Resistance Mechanisms Ceftazidime-Avibactam 
<i>Stenotrophomonas maltophilia</i>Keratitis Related to Therapeutic Contact Lens Misidentified with an Automated Identification System
《Open Journal of Clinical Diagnostics》2015年第2期63-67,共5页Daniel Fatela-Cantillo Javier Crespo-González Blanca Fatela-Cantillo Antonio Fernandez-Suarez Jose Miguel Aguilar Benítez Juan Antonio Saez Nieto Remedios González-Amezcua 
We present a case of keratitis caused by Stenotrophomonas maltophilia in a therapeutic contact lens user with trichiasis and symblepharon. This keratitis was initially diagnosed as caused by Achromobacter xylosoxidans...
关键词：STENOTROPHOMONAS maltophilia KERATITIS CEFTAZIDIME 
Total Alkaloids from Sophora Alopecuroides L.Increase Susceptibility of Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates to Cefotaxime and Ceftazidime被引量：6
《Chinese Journal of Integrative Medicine》2013年第12期945-952,共8页周学章 贾芳 刘晓明 杨聪 赵莉 王玉炯 
Supported by a Sub-project of National Basic Research Program of China(No.2006CB504401);the National Natural Science Foundation of China(No.31060348,No.30860207);Grants of Science and Technology Program of Ningxia to Yujiong Wang(No.Z2006-1-75001,KGZ-12-10-02)
Objective： To evaluate the antimicrobial activity of total alkaloids extracted from Sophorea alopecuroides L. （TASA） against clinical isolated extended-spectrum beta-lactamases （ESBLs） producing Escherichia coil ...
关键词：total alkaloids Sophorea alopecuroides L. extended spectrum β-1actamases antibiotic resistance Escherichia coli 
全选清除导出
共3页<123>
检索报告 对象比较 聚类工具 使用帮助 返回顶部